Long-acting Human Growth Hormone Produced by PROLOR Biotech Inc.

Published:September 4th, 2010

A study published in the Journal Endocrinology confirms the potential of PROLOR long-acting human growth hormone, produced by PROLOR Biotech Inc. The company is dedicated to developing bio better versions of therapeutic proteins. It is currently developing versions of long-acting human growth hormone, interferon beta, factor VII and IX, GLP-1 and other peptides.

The technology of carboxyl terminal peptide is applied to human growth hormone to increase half-life and the bioactivity in order to offer better products than those currently on the market. The design of the long-acting human growth hormone combines the carboxyl terminal peptide of human chorionic gonadotropin to the coding sequence of HGH.

The product is helpful for both adults and children that suffer from growth hormone deficiency.

It is designed to replace therapy that used daily shots with once a week or twice a month injections.

Therapeutic proteins have become important treatments for various diseases and many patients that depend on certain drugs can benefit from new methods of delivery for treatments that can cure or control such diseases.

---